References
- NgKKLovellJFZhengGLipoprotein-inspired nanoparticles for cancer theranosticsAcc Chem Res201144101105111321557543
- PatelSBhirdeAARuslingJFChenXGutkindJSPatelVNano delivers big: designing molecular missiles for cancer therapeuticsPharmaceutics201131345221949900
- PercheFTorchilinVPRecent trends in multifunctional liposomal nanocarriers for enhanced tumor targetingJ Drug Deliv2013201370526523533772
- MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000651–227128410699287
- Van ElmptWZegersCMReymenBMultiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusionEur J Nucl Med Mol Imaging201643224024826338178
- FokasEMcKennaWGMuschelRJThe impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect anti-vascular strategiesCancer Metastasis Rev2012313–482384222825313
- LammersTKiesslingFHenninkWEStormGDrug targeting to tumors: principles, pitfalls and (pre-) clinical progressJ Control Release2012161217518721945285
- JainRKStylianopoulosTDelivering nanomedicine to solid tumorsNat Rev Clin Oncol201071165366420838415
- KuhHJJangSHWientjesMGWeaverJRAuJLDeterminants of paclitaxel penetration and accumulation in human solid tumorJ Pharmacol Exp Ther1999290287188010411604
- MinchintonAITannockIFDrug penetration in solid tumoursNat Rev Cancer20066858359216862189
- LankelmaJDekkerHLuqueFRDoxorubicin gradients in human breast cancerClin Cancer Res1999571703170710430072
- TongRTBoucherYKozinSVWinklerFHicklinDJJainRKVascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumorsCancer Res200464113731373615172975
- IyerAKKhaledGFangJMaedaHExploiting the enhanced permeability and retention effect for tumor targetingDrug Discov Today20061117–1881281816935749
- SekiTCarrollFIllingworthSTumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathwayJ Control Release2011156338138921884739
- EikenesLTariMTuftoIBrulandOSde Lange DaviesCHyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenograftsBr J Cancer2005931818815942637
- KanoMRBaeYIwataCImprovement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signalingProc Natl Acad Sci U S A200710493460346517307870
- LuDWientjesMGLuZAuJLTumor priming enhances delivery and efficacy of nanomedicinesJ Pharmacol Exp Ther20073221808817420296
- IshidaTShiragaEKiwadaHSynergistic antitumor activity of metronomic dosing of cyclophosphamide in combination with doxorubicin-containing PEGylated liposomes in a murine solid tumor modelJ Control Release2009134319420019095022
- NakamuraHDoiYAbu LilaASNagaoAIshidaTKiwadaHSequential treatment of oxaliplatin-containing PEGylated liposome together with S-1 improves intratumor distribution of subsequent doses of oxaliplatin-containing PEGylated liposomeEur J Pharm Biopharm201487114215124361534
- Abu LilaASDoiYNakamuraKIshidaTKiwadaHSequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumorJ Control Release2010142216717319861140
- SakataYOhtsuAHorikoshiNSugimachiKMitachiYTaguchiTLate phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patientsEur J Cancer19983411171517209893658
- DoiYOkadaTMatsumotoHCombination therapy of metronomic S-1 dosing with oxaliplatin-containing polyethylene glycol-coated liposome improves antitumor activity in a murine colorectal tumor modelCancer Sci2010101112470247520731663
- NakataEFukushimaMTakaiYS-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FUOncol Rep200616346547116865244
- IshidaTMaedaRIchiharaMAccelerated clearance of PEGylated liposomes in rats after repeated injectionsJ Control Release2003881354212586501
- BartlettGRColorimetric assay methods for free and phosphorylated glyceric acidsJ Biol Chem1959234346947113641242
- OoyamaAOkaTZhaoHYYamamotoMAkiyamaSFukushimaMAnti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenograftsCancer Lett20082671263618420342
- BhattacharyaASeshadriMOvenSDTóthKVaughanMMRustumYMTumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugsClin Cancer Res200814123926393218559614
- BalasubramaniamPMalathiAViswanathanCA simple technique for hemoglobin estimation to screen for anaemiaIndian J Physiol Pharmacol19923632132141473856
- PaderaTPStollBRTooredmanJBCapenDdi TomasoEJainRKPathology: cancer cells compress intratumour vesselsNature2004427697669514973470
- SafraTMuggiaFJeffersSPEGylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2Ann Oncol20001181029103311038041
- O’BrienMEWiglerNInbarMReduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancerAnn Oncol200415344044914998846
- GradisharWJTjulandinSDavidsonNPhase III trial of nano-particle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancerJ Clin Oncol200523317794780316172456
- LienKGeorgsdottirSSivanathanLChanKEmmeneggerULow-dose metronomic chemotherapy: a systematic literature analysisEur J Cancer2013493387339523880474
- ScharovskyOGMainettiLERozadosVRMetronomic chemotherapy: changing the paradigm that more is betterCurr Oncol2009162715
- JainRKNormalization of tumor vasculature: an emerging concept in antiangiogenic therapyScience20053075706586215637262
- TanakaSAkaikeTWuJModulation of tumor-selective vascular blood flow and extravasation by the stable prostaglandin 12 analogue beraprost sodiumJ Drug Target2003111455212852440
- EpsteinALMizokamiMMLiJHuPKhawliLAIdentification of a protein fragment of interleukin 2 responsible for vasopermeabilityJ Natl Cancer Inst2003951074174912759392
- MonskyWLFukumuraDGohongiTAugmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factorCancer Res199959164129413510463618
- SekiTFangJMaedaHEnhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin applicationCancer Sci2009100122426243019793083
- McKeeTDGrandiPMokWDegradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vectorCancer Res20066652509251316510565
- GoelSDudaDGXuLNormalization of the vasculature for treatment of cancer and other diseasesPhysiol Rev20119131071112121742796